Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07161479Not ApplicableRecruiting

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

Role: collaborator

NCT07344376Phase 3Completed

An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)

Role: collaborator

NCT06897514Recruiting

External Validation of Prediction Algorithm Using Non-invasive Monitoring Device for Intraoperative Hypotension

Role: collaborator

NCT02673424Not ApplicableUnknown

Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis

Role: collaborator

NCT04890171Not ApplicableRecruiting

Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type

Role: collaborator

All 5 trials loaded